Advancements in Neuroimaging Techniques in Encephalopathy

Encephalopathy is a broad category of brain illnesses defined by altered mental status and cognitive dysfunction. Recent advances in neuroimaging technologies and artificial intelligence (AI) have considerably improved the diagnosis, monitoring, and understanding of various types of encephalopathy. This chapter explores recent advancements in neuroimaging modalities, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and functional MRI (fMRI), highlighting their contributions to elucidating the pathophysiology, early detection, and monitoring of encephalopathy. The impact of AI is transformed beyond image enhancement to predictive analytics and personalized medicine. Machine learning (ML) models built on large neuroimaging datasets can forecast illness development, stratify disease severity, and evaluate therapy success more accurately. This skill enables early diagnosis and focused therapy measures, ultimately improving patient outcomes. MRI combining diffusion-weighted imaging (DWI) and susceptibility-weighted imaging (SWI) has a high sensitivity for detecting minor brain abnormalities caused by metabolic, viral, and toxic conditions. CT is important in emergent settings because it allows for the quick assessment of structural brain alterations. PET imaging reveals metabolic changes underlying encephalopathy, which aids in differential diagnosis and therapy planning. fMRI approaches cover resting-state fMRI and task-based fMRI, allowing the assessment of functional connectivity and neurocognitive impairments. In addition, innovations in image processing and ML algorithms improve diagnostic accuracy and prognosis prediction.